These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 3907642

  • 1. Effectiveness of thymostimulin treatment in hepatitis B surface antigen-positive chronic active liver disease. Results of a randomized clinical trial.
    Romeo F, Arcoria D, Palmisano L, Polosa P.
    Arzneimittelforschung; 1985; 35(8):1317-22. PubMed ID: 3907642
    [Abstract] [Full Text] [Related]

  • 2. Thymostimulin in the treatment of hepatitis B surface antigen-positive chronic active hepatitis. Controlled clinical trial--two years follow-up.
    Romeo F, Palmisano L, Arcoria D.
    Arzneimittelforschung; 1987 Apr; 37(4):450-6. PubMed ID: 3300664
    [Abstract] [Full Text] [Related]

  • 3. Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis.
    Lam KC, Lai CL, Trepo C, Wu PC.
    N Engl J Med; 1981 Feb 12; 304(7):380-6. PubMed ID: 7005678
    [Abstract] [Full Text] [Related]

  • 4. [Immunotherapy of chronic active hepatitis (HBsAg+) with calf thymus extract (TFX-Polfa). Clinical evaluation].
    Cianciara J, Babiuch L, Górska E, Kassur B.
    Pol Tyg Lek; 1984 Aug 13; 39(33):1097-101. PubMed ID: 6390376
    [No Abstract] [Full Text] [Related]

  • 5. [Effects of a treatment with a thymus extract (thymostimulin) in acute viral hepatitis B in drug-dependent patients].
    Corridori S, Trespi G, Baldini E, Renzetti I, Calderon W.
    Boll Ist Sieroter Milan; 1984 Aug 13; 63(6):519-28. PubMed ID: 6242017
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of chronic active HBsAg-positive hepatitis with thymostimulin].
    Nardiello S, Russo M, Pizzella T, Galanti B, Giusti G.
    G Ital Chemioter; 1984 Aug 13; 31(1-2):181-4. PubMed ID: 6468826
    [No Abstract] [Full Text] [Related]

  • 7. Treatment with thymic extract TFX for chronic active hepatitis B.
    Dworniak D, Tchórzewski H, Pokoca L, Tkacz B, Drobnik S, Baj Z, Luciak M.
    Arch Immunol Ther Exp (Warsz); 1991 Aug 13; 39(5-6):537-47. PubMed ID: 1841551
    [Abstract] [Full Text] [Related]

  • 8. [Clinical experience with thymostimulin (TP-1) therapy. Preliminary findings].
    Altomonte L, Zoli A, Siena D, Alessi F, Pestillo L, Mirone L.
    Minerva Med; 1986 Jun 23; 77(26):1243-7. PubMed ID: 3725151
    [Abstract] [Full Text] [Related]

  • 9. [Results of the treatment of chronic active hepatitis with thymus extract (TFX-Polfa). (Evaluation of the preliminary stage of clinical studies)].
    Kiczka W, Juszczyk J, Adamek J.
    Pol Tyg Lek; 1987 Feb 16; 42(7):192-6. PubMed ID: 3299322
    [No Abstract] [Full Text] [Related]

  • 10. Chronic delta hepatitis: a difficult problem for the hepatologist.
    Picciotto A, Celle G.
    Hepatogastroenterology; 1984 Aug 16; 31(4):162-3. PubMed ID: 6383995
    [Abstract] [Full Text] [Related]

  • 11. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.
    Bassendine MF, Chadwick RG, Salmeron J, Shipton U, Thomas HC, Sherlock S.
    Gastroenterology; 1981 May 16; 80(5 pt 1):1016-22. PubMed ID: 7009310
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transfer factor in the attempted treatment of patients with HBsAg-positive chronic liver disease.
    Jain S, Thomas HC, Sherlock S.
    Clin Exp Immunol; 1977 Oct 16; 30(1):10-5. PubMed ID: 606432
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Immunosuppressive therapy in patients with HBeAg-positive chronic active hepatitis B?].
    Maier KP, Lepiorz H, Berthold H, Gerok W.
    Leber Magen Darm; 1982 Aug 16; 12(4):150-3. PubMed ID: 7132529
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of serum rosette inhibitory factors in chronic liver disease.
    Zauli D, Bianchi FB, Fusconi M, Crespi C, Pisi E.
    Clin Exp Immunol; 1983 Jul 16; 53(1):145-50. PubMed ID: 6603304
    [Abstract] [Full Text] [Related]

  • 17. [Immunosuppressive treatment of patients with chronic active HBsAg positive hepatitis].
    Tanno H, Fay O, Roldán L, Vorovioff J.
    Acta Gastroenterol Latinoam; 1982 Jul 16; 12(4):323-32. PubMed ID: 7185230
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.